REQUEST A DEMO
Total
USD $0.00
Search more companies

Hybio Pharmaceutical Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Hybio Pharmaceutical Co., Ltd. Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Shenzhen Hanyu Pharmaceutical Co.,Ltd., the company’s predecessor, was established in 2001 with State Drug Supervision and Administration Bureau’s No. [2001]362 “Approval on establishing Shenzhen Hanyu Pharmaceutical Co.,Ltd and Guangdong Provincial Drug Supervision and Administration Bureau’s No. [2001]412 Document. It received Drug Production Permit in April 2003 issued by Guangdong Provincial Drug Supervision and Administration Bureau. On April 2, 2003, it received Business License for Enterprise’s Legal Person with Registration No. 440301110909 issued by Shenzhen Administration of Industry and Commerce. On November13, 2009, it held inaugural meeting and the first shareholders meeting of the stock limited and on November 13, 2009, it registered its change in Shenzhen Market Supervision Administration of Shenzhen Municipality ( the former Shenzhen Administration for Industry and Commerce), changing its name to Shenzhen HYBIO PHARMACEUTICAL CO., LTD. and received a new Business License for Enterprise’s Legal Person with Registration No. 440301103008894.

Headquarters
Hanyu Innovation Industry Building, No. 7, Guansheng 4th Road, Guanlan High-tech Park, Longhua District, Shenzhen, Guangdong Province
Shenzhen; Guangdong; Postal Code: 518110

Contact Details: Purchase the Hybio Pharmaceutical Co., Ltd. report to view the information.

Website: http://www.hybio.com.cn

Basic Information
Total Employees:
Purchase the Hybio Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Hybio Pharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the Hybio Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Hybio Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
April 02, 2003
Key Executives
Purchase this report to view the information.
Executive President
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
12.41%
Purchase this report to view the information.
8.15%
Purchase this report to view the information.
4%
Purchase this report to view the information.
2.99%
Purchase this report to view the information.
2.46%
Subsidiaries
Gansu Chengji Biological Pharmaceutical Co., Ltd.
Hainan Haotian Health Technology Co., Ltd.
Hanyu Biotechnology (Dali) Co., Ltd.
Company Performance
Financial values in the chart are available after Hybio Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-6.56%
Total operating revenue
-15.35%
Operating profit (EBIT)
83.92%
Net Profit (Loss) for the Period
80.29%
Total assets
-5.3%
Total equity
-36.44%
Operating Profit Margin (ROS)
33.62%
Net Profit Margin
35.72%
Return on Equity (ROE)
10.91%
Debt to Equity Ratio
112.74%
Quick Ratio
-0.06%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?